Glycans as Biomarkers and Functional Effectors in Diabetes and Cardiovascular Diseases | GlycanAge

Glycans as Biomarkers and Functional Effectors in Diabetes and Cardiovascular Diseases

Professional headshot of Prof Gordan Lauc, PhD
Author: Prof Gordan Lauc, PhD
Calendar icon
Published: March 24, 2020
Glycans as Biomarkers and Functional Effectors in Diabetes and Cardiovascular Diseases

Professional head shot of Prof Gordan Lauc, PhD
Author: Prof Gordan Lauc, PhD
Calendar icon
Category: Glycoscience

Glycan science and biological age

Go deeper with GlycanAge for research and cohort studies, peer-reviewed GlycanAge research case studies, and methodology behind glycan-based biological age testing.

2 glycanage testing kits

The Future of Healthcare is Preventative, Personalised, and Powered by Glycans

Whether you’re improving your own health, supporting patients, or driving research, GlycanAge helps you turn science into action.

Other articles you may like:
Blog image
Glycoscience The GlycanAge Team

Measuring HRT Response in Clinical Practice: Why Glycans Beat Hormone Snapshots

Explore the advantages of glycans over hormone snapshots in assessing HRT response, enhancing clinical practice and patient outcomes.

Calendar icon Published:
August 28, 2026 Reading time icon Reading time:
10 minutes
Read the full article
Blog image
Glycoscience The GlycanAge Team

Integrating Biological Age Testing Into a Functional Medicine Practice: A Clinical Playbook

Enhance your functional medicine practice by learning to incorporate biological age testing. Explore our clinical playbook for expert guidance and strategies.

Calendar icon Published:
August 27, 2026 Reading time icon Reading time:
10 minutes
Read the full article